Xlife Sciences acquired a 50% stake in palleos healthcare 

Xlife Sciences – the Switzerland-based company engaged in researching, developing and commercialising therapeutics and medicines for the treatment of diseases – has acquired a 50% stake in palleos healthcare GmbH, a Germany-based clinical research organization that provides of drug development and sponsorship services in all study phases, for a consideration of EUR 5.21m.

The consideration EUR 4m paid in cash and equity consideration of EUR 1.21m pid via issuance of 40,000 shares of Xlife Sciences. Xlife Sciences will pay an additional amount on closing date. The transaction values equity of palleos at EUR 10.4m.

 

The team

Xlife Sciences AG‘s Chief Executive Officer Oliver Baumann and Chief Financial Officer Beat Klaui acted in this transaction. The company has also been advised for legal aspects by Bette Westenberger Brink.

Xlife Sciences acquired a 50% stake in palleos healthcare 

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram